Azathioprine in dermatology

Journal of the American Academy of Dermatology

Volumn 25, Issue 2, 1991, Pages 281-286

  Younger, I R ^a   Harris, D W S ^a   Colver, G B ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

BONE MARROW SUPPRESSION; DERMATOMYOSITIS; ECZEMA; HUMAN; IMMUNE DEFICIENCY; LIVER TOXICITY; LUPUS ERYTHEMATOSUS; PEMPHIGOID; PEMPHIGUS; PRIORITY JOURNAL; REVIEW; WEGENER GRANULOMATOSIS;

AZATHIOPRINE; DRUG INTERACTIONS; ECZEMA; HUMAN; LEUKOPENIA; PEMPHIGOID, BULLOUS; PEMPHIGUS; SKIN DISEASES;

EID: 0025778660     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0190-9622(91)70196-9     Document Type: Article

References (56)

1. The initial study of the immunosuppressive effects of 6-mercaptopurine and azathioprine in organ transplantation
2. Azathioprine
3. Significance of azathioprine metabolites
4. Antibody production in immunosuppressed recipients of renal allografts
5. Effects of azathioprine therapy on bone marrow-dependent and thymus-dependent cells in man
6. Activation of human B-lymphocytes
7. Significance of azathioprine metabolites
8. The anti-inflammatory effect of some immunosuppressive agents
9. In vitro inhibition of prostaglandin production by azathioprine and 6-mercaptopurine
10. Cytotoxic and immunosuppressive agents
11. Azathioprine hypersensitivity
12. Erythroid toxicity of azathioprine. Macrocytosis and selective marrow hypoplasia
13. Fast atrial fibrillation induced by treatment of psoriasis with azathioprine
14. Viral infections in renal allograft recipients treated with long-term immunosuppression
15. Norwegian scabies during immunosuppressive therapy
16. Rheumatoid arthritis: treatment with azathioprine: clinical side effects and laboratory abnormalities
17. Disseminated superficial porokeratosis and immunosuppression
18. Porokeratosis of Mibelli in an immunosuppressed patient
19. Immunodeficiency in humans as a risk factor in the development of malignancy
20. Depressed immunity and the development of cancer
21. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs
22. Somatic mutation and chronic disease
23. Development and incidence of cancer following cyclosporin therapy
24. The prevalence of skin disorders in renal allograft recipients receiving cyclosporin A compared with those receiving azathioprine
25. Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from mother to the fetus
26. Successful pregnancies in women treated by dialysis and kidney transplantation
27. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients
28. Pregnancy in women with renal allografts
29. Pemphigus treatment with azathioprine
30. Treatment of pemphigus vulgaris
31. Azathioprine in the treatment of pemphigus vulgaris
32. A controlled trial of azathioprine in the treatment of pemphigoid
33. The treatment of bullous pemphigoid
34. Azathioprine for pemphigus and pemphigoid, a 4-year follow-up
35. Treatment of chronic actinic dermatitis with azathioprine
36. Dermatopharmacology: drugs around the corner
37. Immunoglobulin E in “healed” atopic dermatitis and after treatment with corticosteroids and azathioprine
38. Treatment of eczema with cyclophosphamide and azathioprine
39. Long-term maintenance therapy with azathioprine in systemic lupus erythematosus
40. Long-term survival of lupus nephritis patients treated with azathioprine and prednisolone
41. Successful treatment of generalized discoid skin lesions with azathioprine
42. Resistant discoid lupus erythematosus of palms and soles: successful treatment with azathioprine
43. Treatment of dermatomyositis [Letter]
44. Treatment of psoriasis with azathioprine
45. Two cases of distinctive exudative discoid and lichenoid chronic dermatosis of Sulzberger and Garbe responding to azathioprine
46. Wegener's granulomatosis—controlled by azathioprine and corticosteroids
47. Immunosuppressive agents
48. Azathioprine therapy in the management of persistent erythema multiforme
49. Pityriasis rubra pilaris
50. Treatment of pityriasis rubra pilaris with azathioprine
51. Pyoderma gangrenosum treated with azathioprine and prednisolone
52. Use of azathioprine in the treatment of dermatitis ulcerosa
53. Idiopathic pyoderma gangrenosum and impaired lymphocyte function: failure of azathioprine and corticosteroid therapy
54. Pyoderma gangrenosum in immunosuppressed patients
55. Acne fulminans with circulating immune complexes and leukemoid reaction treated with steroids and azathioprine
56. A clinical and investigative study of herpes gestationis and polymorphic eruption of pregnancy